Image of ALLHAT logo; links to ALLHAT Study website The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
Skip Navigation Links Highlights of Research Already Accomplished or In Progress

The Final Results of ALLHAT  were published in 2002. Since then, the ALLHAT research group has examined :

  • Blood Pressure
    • predictors of blood pressure response overall
    • predictors within randomized treatment groups
  • Diabetes
    • ALLHAT results by diabetes subgroups
    • diabetes incidence by randomized treatment group
  • Heart Failure
    • validity of the ALLHAT heart failure outcome
    • heart failure by randomized treatment group
    • heart failure with preserved and reduced ejection fraction
    • post-heart failure mortality risk
  • Chronic Kidney Disease
    • ALLHAT results by CKD subgroups,
    • CKD incidences by randomized treatment group
    • the prognostic value of CKD groups for cardiovascular and renal outcomes
  • Atrial Fibrillation
    • incidence of atrial fibrillation by randomized treatment group
  • Metabolic Syndrome
    • ALLHAT results by metabolic syndrome subgroups overall
    • ALLHAT results by race subgroups

Links to ALLHAT Papers and Research

Logo for University of Texas Health Science Center at Houston, School of Public Health; links to School of Public Health website
Coordinating Center for Clinical Trials
E-mail Web Comments